APA

Godier A., Martin A., Leblanc I., Mazoyer E., Horellou M., Ibrahim F., Flaujac C., Golmard J., Rosencher N. & Gouin-Thibault I. (20160628). Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations. : Thrombosis research.

Chicago

Godier Anne, Martin Anne-Céline, Leblanc Isabelle, Mazoyer Elisabeth, Horellou Marie-Hélène, Ibrahim Firas, Flaujac Claire, Golmard Jean-Louis, Rosencher Nadia and Gouin-Thibault Isabelle. 20160628. Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations. : Thrombosis research.

Harvard

Godier A., Martin A., Leblanc I., Mazoyer E., Horellou M., Ibrahim F., Flaujac C., Golmard J., Rosencher N. and Gouin-Thibault I. (20160628). Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations. : Thrombosis research.

MLA

Godier Anne, Martin Anne-Céline, Leblanc Isabelle, Mazoyer Elisabeth, Horellou Marie-Hélène, Ibrahim Firas, Flaujac Claire, Golmard Jean-Louis, Rosencher Nadia and Gouin-Thibault Isabelle. Peri-procedural management of dabigatran and rivaroxaban: Duration of anticoagulant discontinuation and drug concentrations. : Thrombosis research. 20160628.